Results 1 to 10 of about 3,896,157 (226)

Erosive arthritis and anti-cyclic citrullinated peptide antibodies in systemic sclerosis

open access: yesIndian Journal of Rheumatology, 2017
Background: The frequency and characteristics of erosive arthritis in systemic sclerosis (SSc) remains unclear. The aim of the study was to determine the prevalence and characteristics of erosive arthritis and to define the role of anti-CCP antibodies in
A Abdessemed   +10 more
doaj   +2 more sources

Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvement [PDF]

open access: yesBrazilian Journal of Medical and Biological Research, 2008
The objective of the present research was to evaluate the usefulness of anti-cyclic citrullinated peptide (anti-CCP) antibodies and the IgM rheumatoid factor (IgM RF) test for the differential diagnosis of leprosy with articular involvement and ...
S.L.E. Ribeiro   +4 more
doaj   +2 more sources

Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis

open access: yesBMC Musculoskeletal Disorders, 2007
Background Anti-cyclic citrullinated peptide (anti-CCP) antibodies have been of diagnostic value in Northern European Caucasian patients with rheumatoid arthritis (RA).
Theodoridou Katerina   +4 more
doaj   +1 more source

ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES IN RHEUMATOID ARTHRITIS PATIENTS

open access: yesPakistan Armed Forces Medical Journal, 2018
Objective: To detect the anti cyclic citrullinated peptide (Anti-CCP) antibody in rheumatoid arthritis (RA) patients to determine its diagnostic value in Pakistani patients. Study Design: Cross sectional study.
Amer Fakhr   +4 more
doaj   +2 more sources

The relationship between the presence of anti-cyclic citrullinated peptide antibodies and clinical phenotype in very early rheumatoid arthritis

open access: yesBMC Musculoskeletal Disorders, 2010
Background Anti-cyclic citrullinated peptide (anti-CCP) antibodies are highly specific for RA, but are not detectable in all RA patients. The aim of this study was to establish whether the clinical phenotypes of anti-CCP positive and negative disease are
Cader Mohammed Z   +3 more
doaj   +1 more source

Correlation between anti-cyclic citrullinated peptide antibodies and the severity of clinical manifestation, laboratory manifestation, and radiological joint destruction in rheumatoid arthritis patients

open access: yesIndonesian Journal of Rheumatology, 2018
Background. The second generation anti-cyclic citrullinated peptide test (CCP2) displays sensitivity comparable to that of rheumatoid factor (RF) (approximately 80%) but with superior specificity (98%) .
Mat Suwito   +4 more
doaj   +1 more source

Possible Role of Anti-Cyclic Citrullinated Peptide Antibody (Anti-CCP Ab) in Rheumatic Diseases

open access: yesDiyala Journal of Medicine, 2019
Background: Anti-cyclic citrullinated peptide (anti-CCP) antibodies are highly specific for RA, but are not detectable in all RA patients, in addition their usefulness to identify rheumatic arthritis (RA) from other rheumatic diseases presenting with ...
Eman Sh Al-Obeidy   +2 more
doaj   +2 more sources

Factors related to seroconversion of anti-cyclic citrullinated peptide antibody after the onset of rheumatoid arthritis: a case-control study and systematic review

open access: yesImmunological Medicine
Anti-cyclic citrullinated peptide (CCP) antibodies typically present before rheumatoid arthritis (RA) but appear (seroconvert) after disease onset in some patients. This study analyzed factors related to anti-CCP seroconversion.
Yui Kosumi   +8 more
doaj   +1 more source

Diagnostic Usefulness of Anti-Cyclic Citrullinated Peptide and Anti-Mutated Citrullinated Vimentin Antibodies in the Diagnosis of Seronegative Rheumatoid Arthritis Patients

open access: yesJournal of Islamic International Medical College, 2016
Objective: To determine the usefulness of anti-Cyclic Citrullinated Peptide and anti-Mutated Citrullinated Vimentin antibody in the diagnosis of seronegative rheumatoid arthritis. Study Design: Descriptive Cross-sectional.
Bushra Gohar Shah , Asma Saeed , Mohammad Faisal Khan , Hamid Javaid Quershi
doaj  

Home - About - Disclaimer - Privacy